Ana Lucrecia Woodward

Array ( [id] => 7670152 [patent_doc_number] => 20110319421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'BENZENESULFONAMIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/187885 [patent_app_country] => US [patent_app_date] => 2011-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12405 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561982 [patent_doc_number] => 20110275815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'BENZYLPIPERAZINE DERIVATIVES AS MOTILIN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/186869 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17323 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275815.pdf [firstpage_image] =>[orig_patent_app_number] => 13186869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10613777 [patent_doc_number] => 09333205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Isoxazolo-quinazolines as modulators of protein kinase activity' [patent_app_type] => utility [patent_app_number] => 13/813200 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27642 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725576 [patent_doc_number] => 08404691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Imidazothiazole derivatives having proline ring structure' [patent_app_type] => utility [patent_app_number] => 13/183762 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42286 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574112 [patent_doc_number] => 20110269768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'UROTENSIN II RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/183121 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38257 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269768.pdf [firstpage_image] =>[orig_patent_app_number] => 13183121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875861 [patent_doc_number] => 08470828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Anellated pyridine compounds' [patent_app_type] => utility [patent_app_number] => 13/171499 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23380 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13171499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8822194 [patent_doc_number] => 20130123239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'COMPOUNDS HAVING TRPV1 ANTAGONISTIC ACTIVITY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/704770 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 237872 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487713 [patent_doc_number] => 20110251202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => '1,3-Dihydro-imidazo[4,5-c]quinolin-2-ones as Lipid Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/165144 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35296 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251202.pdf [firstpage_image] =>[orig_patent_app_number] => 13165144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663882 [patent_doc_number] => 20110313151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'ANELLATED PYRIDINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/161548 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30737 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313151.pdf [firstpage_image] =>[orig_patent_app_number] => 13161548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063527 [patent_doc_number] => 20110245268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/161205 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 99587 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245268.pdf [firstpage_image] =>[orig_patent_app_number] => 13161205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063051 [patent_doc_number] => 20110245500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'MELANOCORTIN RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/158920 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23068 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245500.pdf [firstpage_image] =>[orig_patent_app_number] => 13158920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7491059 [patent_doc_number] => 20110237795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'MELANOCORTIN RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/158734 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23066 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237795.pdf [firstpage_image] =>[orig_patent_app_number] => 13158734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501794 [patent_doc_number] => 20110263628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'N-HYDROXYAMIDE DERIVATIVES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/155411 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45762 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263628.pdf [firstpage_image] =>[orig_patent_app_number] => 13155411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7491053 [patent_doc_number] => 20110237792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS' [patent_app_type] => utility [patent_app_number] => 13/152356 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15311 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237792.pdf [firstpage_image] =>[orig_patent_app_number] => 13152356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580934 [patent_doc_number] => 20110294817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'N-[PIPERAZINYL HETARYL]ARYLSUFONAMIDE COMPOUNDS WITH AFFINITY FOR THE DOPAMINE D3 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/117269 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32769 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294817.pdf [firstpage_image] =>[orig_patent_app_number] => 13117269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239248 [patent_doc_number] => 08604040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Pyridinylcarboxylic acid derivatives as fungicides' [patent_app_type] => utility [patent_app_number] => 13/117041 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76126 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13117041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534781 [patent_doc_number] => 09260400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'I-arylpiperazinic ligands of 5-HT7 receptor and use thereof' [patent_app_type] => utility [patent_app_number] => 14/119860 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12349 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571942 [patent_doc_number] => 08338590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Substituted oxindole derivatives and medicaments containing the same' [patent_app_type] => utility [patent_app_number] => 13/112550 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38162 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720879 [patent_doc_number] => 20120010214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => '3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES' [patent_app_type] => utility [patent_app_number] => 13/103993 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17246 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010214.pdf [firstpage_image] =>[orig_patent_app_number] => 13103993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177647 [patent_doc_number] => 08178674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Process for the preparation of ziprasidone' [patent_app_type] => utility [patent_app_number] => 13/100833 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5244 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178674.pdf [firstpage_image] =>[orig_patent_app_number] => 13100833 [rel_patent_id] =>[rel_patent_doc_number] =>)